Addex Therapeutics annual operating margin
2017
2018
2019
2020
2021
2022
2023
2024
Addex Therapeutics Operating Margin Growth & History (ADXN)
Addex Therapeutics's operating margin was −681.82% for fiscal 2024.
View full Addex Therapeutics company overviewAddex Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −681.82% | −542.76 pp |
| 2023 | 2023-12-31 | −139.06% | +601.99 pp |
| 2022 | 2022-12-31 | −741.04% | −209.35 pp |
| 2021 | 2021-12-31 | −531.70% | −192.81 pp |
| 2020 | 2020-12-31 | −338.88% | +189.71 pp |
| 2019 | 2019-12-31 | −528.59% | −505.02 pp |
| 2018 | 2018-12-31 | −23.57% | +623.58 pp |
| 2017 | 2017-12-31 | −647.15% | — |
Addex Therapeutics quarterly operating margin
Q2.21
Q2.22
Q2.23
Q2.24
Q2.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2025 | 2025-06-30 | −2,014.84% | −1560.81 pp |
| Q2 2024 | 2024-06-30 | −780.13% | — |
| Q2 2023 | 2023-06-30 | −403.69% | — |
| Q2 2022 | 2022-06-30 | −3,868.04% | — |
| Q2 2021 | 2021-06-30 | −454.03% | — |
Addex Therapeutics operating margin trends
Over the last five reported fiscal years, Addex Therapeutics's operating margin decreased from −528.59% to −681.82%, a change of −153.22 percentage points. The latest reported quarter, Q2 2025, shows −2,014.84%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Addex Therapeutics filings at SEC.gov ↗